LeMaitre Vascular Confirms Strong Q1 2026 Results, CEO Adopts 10b5-1 Plan to Sell Shares
LMAT sits 44% above its 52-week low of $78.01.
Summary
LeMaitre Vascular filed its Q1 2026 10-Q, confirming strong financial results with double-digit growth in sales and EPS, while also disclosing that its CEO adopted a Rule 10b5-1 plan to sell up to 200,000 shares.
Key Events · Earnings and Guidance · LMAT
-
Strong Q1 2026 Financial Performance Confirmed
The company reported Q1 2026 net sales of $66.6 million, an 11% increase from $59.9 million in Q1 2025. Net income rose 42% to $15.7 million, and diluted EPS increased 42% to $0.68, confirming previously announced headline figures.
-
Gross Margin Expansion
Gross profit increased by 17% to $48.4 million, with gross margin expanding by 350 basis points to 72.7% in Q1 2026, driven by higher selling prices, manufacturing efficiencies, and favorable product mix.
-
CEO Adopts Rule 10b5-1 Selling Plan
Chairman and CEO George W. LeMaitre adopted a Rule 10b5-1 trading arrangement on March 12, 2026, to sell up to 200,000 shares of common stock by March 10, 2028. This represents a potential sale of approximately $22.4 million based on the current stock price.
-
Dividend Declaration Maintained
The Board of Directors approved a quarterly cash dividend of $0.25 per share, payable on June 4, 2026, consistent with the increased dividend announced in February 2026.
Analysis · LMAT · Industrial Applications And Services
This 10-Q filing provides detailed financial results for Q1 2026, confirming the strong performance previously announced in an 8-K and news release on May 5, 2026. The company reported significant increases in net sales, gross profit, net income, and diluted EPS, demonstrating robust operational execution. A new material disclosure is the adoption of a Rule 10b5-1 trading plan by Chairman and CEO George W. LeMaitre to sell up to 200,000 shares over the next two years. While pre-planned, this represents a notable potential distribution of shares by a key executive, which could be perceived as a mixed signal despite the strong financial backdrop. Investors should monitor the actual sales under this plan and the company's continued growth trajectory.
At the time of this filing, LMAT was trading at $112.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $78.01 to $118.01. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.